Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Silibinin may help promote hair growth and treat hair loss.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Oral cyclosporin doesn't stop hair loss.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Repurposing existing drugs can improve cancer treatment but faces challenges.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Cyclosporin promotes hair growth by boosting cell growth and reducing cell death.

New and repurposed treatments are improving outcomes in dermatology.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Co-trimoxazole may help treat autoimmune diseases.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.

Stopping antifungal prophylaxis after 1 year may be safe for low-risk transplant patients.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.